Skip to content
Home/Companies/Biotech/Modern Meadow
Modern Meadow

Modern Meadow

Biotech·United States·Active·7yr hold
Entry
2019
Hold
7yr
Status
Active

Who owns Modern Meadow?

Modern Meadow is currently owned by Evonik Venture Capital through Evonik Venture Capital (2012 vintage), since 2019.

Hand-verified · updated 2026-08-10

Evonik Venture Capital
Investor
Evonik Venture Capital
Evonik Venture Capital · 2012 · VC

Key facts

HQUnited States
SectorBiotech
StatusActive
Websitewww.modernmeadow.com

More from Evonik Venture Capital

Other portfolio companies in the same fund.

Abolis
Active
BiotechFrance· 2024
JLand Biotech
Active
BiotechChina· 2024
Interface Polymers
Interface Polymers
Active
IndustrialsUnited Kingdom· 2023
SuperC
Active
ClimateTechChina· 2023
Allay Therapeutics
Allay Therapeutics
Active
MedTechUnited States· 2022
Biograil
Biograil
Active
MedTechDenmark· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Modern Meadow

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Modern Meadow.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue